Fractyl Health (GUTS) Change in Account Payables (2023 - 2026)
Fractyl Health (GUTS) reported Change in Account Payables of $75000.0 for Q1 2026, up 104.26% year-on-year from $36718.1 in Q1 2025, and down 76.42% quarter-over-quarter from $318000.0 in Q4 2025.
Fractyl Health (GUTS) has 4 years of Change in Account Payables data on file, last reported at $75000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 104.26% year-over-year to $75000.0; the trailing twelve-month figure through Mar 2026 stood at $170000.0 (down 60.56% YoY), and the FY2025 full-year result was -$1.7 million, down 162.03% from the prior year.
- Change in Account Payables for Q1 2026 stood at $75000.0, down from $318000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.4 million in Q2 2025 and bottomed at -$2.7 million in Q3 2025.
- A 4-year average of $51384.6 and a median of $75000.0 in 2026 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 1854.55% in 2024 and plunged 652.12% in 2025, its largest moves.
- Tracing GUTS's Change in Account Payables over 4 years: stood at $77000.0 in 2023, then surged by 1854.55% to $1.5 million in 2024, then tumbled by 78.87% to $318000.0 in 2025, then sank by 76.42% to $75000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $75000.0, $318000.0, and -$2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 75,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75,000.00 |
| Mar 31, 2026 | 75,000.00 |
| Dec 31, 2025 | 318,000.00 |
| Dec 31, 2025 | 318,000.00 |
| Sep 30, 2025 | -2.66 Mn |
| Sep 30, 2025 | -2.66 Mn |
| Jun 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.43 Mn |
| Mar 31, 2025 | -1.76 Mn |
| Mar 31, 2025 | -1.76 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | -353,000.00 |
| Sep 30, 2024 | -353,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 494,000.00 |
| Mar 31, 2024 | 494,000.00 |
| Dec 31, 2023 | 77,000.00 |
| Dec 31, 2023 | 77,000.00 |
| Sep 30, 2023 | -70,000.00 |
| Sep 30, 2023 | -70,000.00 |
| Jun 30, 2023 | -212,000.00 |
| Jun 30, 2023 | -212,000.00 |
| Mar 31, 2023 | -222,000.00 |
| Mar 31, 2023 | -222,000.00 |